Related Content
Search Google Scholar for:
More Information
Related Jobs from ScienceCareers
|
|
Science 7 February 2003: Vol. 299. no. 5608, pp. 884 - 887 DOI: 10.1126/science.1079085
|
|
Reports
Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein
Gerd G. Kochendoerfer,1*
Shiah-Yun Chen,1
Feng Mao,1
Sonya Cressman,1
Stacey Traviglia,1
Haiyan Shao,1
Christie L. Hunter,1§
Donald W. Low,1
E. Neil Cagle,1
Maia Carnevali,1
Vincent Gueriguian,1
Peter J. Keogh,1
Heather Porter,1
Stephen M. Stratton,1
M. Con Wiedeke,1
Jill Wilken,1
Jie Tang,1
Jay J. Levy,1¶
Les P. Miranda,1
Milan M. Crnogorac,1
Suresh Kalbag,1
Paolo Botti,1#
Janice Schindler-Horvat,1
Laura Savatski,2
John W. Adamson,2
Ada Kung,1
Stephen B. H. Kent,1**
James A. Bradburne1
We report the design and total chemical synthesis of
"synthetic erythropoiesis protein" (SEP), a 51-kilodalton
protein-polymer construct consisting of a 166-amino-acid polypeptide
chain and two covalently attached, branched, and monodisperse polymer
moieties that are negatively charged. The ability to control the
chemistry allowed us to synthesize a macromolecule of precisely defined covalent structure. SEP was homogeneous as shown by high-resolution analytical techniques, with a mass of 50,825 ±10 daltons by
electrospray mass spectrometry, and with a pI of 5.0. In cell and
animal assays for erythropoiesis, SEP displayed potent biological
activity and had significantly prolonged duration of action in vivo.
These chemical methods are a powerful tool in the rational design of protein constructs with potential therapeutic applications.
1 Gryphon Therapeutics, 250 East Grand Avenue,
Suite 90, South San Francisco, CA 94080, USA.
2 The
Blood Research Institute, Blood Center of Southeastern Wisconsin, 8727 Watertown Plank Road, Milwaukee, WI 53226, USA.
*
To whom correspondence should be addressed. E-mail:
Gkochendoerfer{at}gryphonRX.com
Present address: Department of Biochemistry and
Molecular Biology, Faculty of Medicine, University of British Columbia,
2146 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.
Present address: Diosynth RTP, Inc., 3000 Weston
Parkway, Cary, NC 27513, USA.
§
Present address: Applied Biosystems, 850 Lincoln
Centre Drive, Foster City, CA 94404, USA.
Present address: Celera Genomics, 180 Kimball Way, South San
Francisco, CA 94080, USA.
¶
Present address: Midwest Biotech, 12690 Ford Drive, Fishers,
IN 46038-1151, USA.
#
Present address: GeneProt Inc., 2 Pré-de-la-Fontaine,
1217 Meyrin/Geneva, Switzerland.
**
Present address: Departments of Biochemistry & Molecular Biology, and The University of Chicago, Chicago, IL 60637, USA.
Read the Full Text
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Novel Erythropoiesis-Stimulating Agents: A New Era in Anemia Management.
- I. C. Macdougall (2008)
Clin. J. Am. Soc. Nephrol.
3, 200-207
| Abstract »
| Full Text »
| PDF »
- Convergent chemical synthesis and high-resolution x-ray structure of human lysozyme.
- T. Durek, V. Yu. Torbeev, and S. B. H. Kent (2007)
PNAS
104, 4846-4851
| Abstract »
| Full Text »
| PDF »
- New agents that stimulate erythropoiesis.
- H. F. Bunn (2007)
Blood
109, 868-873
| Abstract »
| Full Text »
| PDF »
- Glycopeptides as versatile tools for glycobiology.
- T. Buskas, S. Ingale, and G.-J. Boons (2006)
Glycobiology
16, 113R-136R
| Abstract »
| Full Text »
| PDF »
- His6 tag-assisted chemical protein synthesis.
- D. Bang and S. B. H. Kent (2005)
PNAS
102, 5014-5019
| Abstract »
| Full Text »
| PDF »
- Total chemical synthesis and electrophysiological characterization of mechanosensitive channels from Escherichia coli and Mycobacterium tuberculosis.
- D. Clayton, G. Shapovalov, J. A. Maurer, D. A. Dougherty, H. A. Lester, and G. G. Kochendoerfer (2004)
PNAS
101, 4764-4769
| Abstract »
| Full Text »
| PDF »
- Structure-based substitutions for increased solubility of a designed protein.
- L. K. Mosavi and Z.-y. Peng (2003)
Protein Eng. Des. Sel.
16, 739-745
| Abstract »
| Full Text »
| PDF »
|
|